The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More Post author:Sam Post published:November 21, 2017 Post category:BioPharma Keith Speights, writing for The Motley Fool, notes one biotech that’s booming. Source: BioSpace You Might Also Like AEterna Zentaris To Announce Fourth Quarter And Full-Year 2016 Financial And Operating Results On March 15, 2017 March 5, 2017 ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 February 12, 2017 Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017
AEterna Zentaris To Announce Fourth Quarter And Full-Year 2016 Financial And Operating Results On March 15, 2017 March 5, 2017
ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 February 12, 2017
Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017
